Information for COPD Support groups  for the benefit of the COPD patient
Home   FAQ Contact  
 Home
 Home
Member Directories
Speakers Directory
Calendar of Events
About Us
Members Area

Contact Us

COPD Council
131 DW Highway #627
Nashua, NH 03060
 

Email Addresses:

Webmaster: Webmaster@COPDCouncil.org

Calendar Information: Events@COPDCouncil.org

Speaker Information: Speakers@COPDCouncil.org

Print this Page


  

Check here for all
the latest COPD
related news


   Latest Event News

NEWS RELEASE RIDGEFIELD, CT (February 2, 2004) -- Boehringer Ingelheim Pharmaceuticals, Inc. announced today that the United States Food and Drug Administration (FDA) has approved Spiriva® HandiHaler® (tiotropium bromide inhalation powder) for the long-term, once-daily maintenance treatment of bronchospasm associated with Chronic Obstructive Pulmonary Disease (COPD). see news release at:
http://www.pfizer.com/are/news_
releases/2004pr/mn_2004_0202.html.



Copyright 2003-2008 COPDCouncil.org